Clinical trials: Nasophayngeal Carcinoma Between Stage II and IVb
Nasophayngeal Carcinoma Between Stage II and IVb
A Randomized Phase II Study of Concurrent Chemoradiation With Every 3 Week of Cisplatin vs With Weekly Cisplatin in Locally Advanced Nasopharyngeal Carcinoma
The study try to show the weekly cisplatin based CCRT is not inferior to 3-weekly cisplabe based CCRT in terms of 3-yr progression free survival rate in advanced nasopharyngeal carcinoma
- Trial name
- NCT01171781
- Testing
- cisplatin (3 weekly), cisplatin (weekly)
- Where
- South Korea
- Volunteers
- 110 people
- Sponsor
- Samsung Medical Center